These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6993914)

  • 21. [The correlation of atrial natriuretic peptide values with those of renin, angiotensin and aldosterone in hypertension patients below and above 50].
    González Carmona VM; García R; Camacho P; Jerjes Sánchez C; Arévila N; Hernández H; Nieto Castillo S
    Arch Inst Cardiol Mex; 1993; 63(5):435-9. PubMed ID: 8291930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM
    Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
    [No Abstract]   [Full Text] [Related]  

  • 23. [Beta blocking agents and arterial hypertension].
    Squadrito G
    G Clin Med; 1979 May; 60(5):347-65. PubMed ID: 39861
    [No Abstract]   [Full Text] [Related]  

  • 24. The control of hypertension: a therapeutic breakthrough.
    Kaplan NM
    Am Sci; 1980; 68(5):537-45. PubMed ID: 6999952
    [No Abstract]   [Full Text] [Related]  

  • 25. Renin-angiotensin-aldosterone system, RR interval, and blood pressure variability during postural changes in borderline arterial hypertension.
    Duprez DA; De Sutter JH; De Buyzere ML; Rietzschel ER; Rimbaut S; Kaufman JM; Van Hoecke MJ; Clement DL
    Am J Hypertens; 1995 Jul; 8(7):683-8. PubMed ID: 7546493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension and the brain.
    Sandok BA; Whisnant JP
    Arch Intern Med; 1974 Jun; 133(6):947-54. PubMed ID: 4597952
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated sympathetic nerve activity in patients with accelerated essential hypertension.
    Matsukawa T; Mano T; Gotoh E; Ishii M
    J Clin Invest; 1993 Jul; 92(1):25-8. PubMed ID: 8325991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation and correlation of various hemodynamic and humoral parameters in stable essential hypertension].
    Licata G; Novo S; Salerno L; Scaglione R; Capuana G; Di Paola G
    Boll Soc Ital Cardiol; 1981; 26(11):1667-74. PubMed ID: 6758817
    [No Abstract]   [Full Text] [Related]  

  • 32. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic factors associated with volume-sensitive hypertension.
    Williams GH
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):41-4. PubMed ID: 15134799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity.
    Lim PO; Jung RT; MacDonald TM
    J Hum Hypertens; 2002 Mar; 16(3):153-8. PubMed ID: 11896503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease.
    Gjørup PH; Sadauskiene L; Wessels J; Nyvad O; Strunge B; Pedersen EB
    Am J Hypertens; 2007 Jan; 20(1):44-52. PubMed ID: 17198911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antihypertensive effect of carteolol, a beta-receptor blockader, in essential hypertension and its action on the renin-aldosterone system].
    Hata S; Kunita H
    Horumon To Rinsho; 1977 Aug; 25(8):907-15. PubMed ID: 334398
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exaggerated blood pressure response to exercise is associated with augmented rise of angiotensin II during exercise.
    Shim CY; Ha JW; Park S; Choi EY; Choi D; Rim SJ; Chung N
    J Am Coll Cardiol; 2008 Jul; 52(4):287-92. PubMed ID: 18634984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.